Massage Therapy for Pain and Anxiety in Gynecologic Cancer Patients

This study is looking at whether it's practical to offer massage therapy to women with gynecologic cancer while they are receiving infusion treatments (like chemotherapy or immunotherapy). Researchers want to see if they can successfully recruit and keep participants, and if they can measure changes in pain and anxiety before and after massage. You would be eligible if you are a woman between 18 and 85 years old with gynecologic cancer, receiving your first infusion treatment. The study is trying to enroll 24 participants. The main goal is to understand if this type of study can be done effectively, not to prove if massage works yet.

Study design
This study is an interventional study with an unclear phase, planning to enroll 24 participants. It will compare massage therapy to an attention control group where a therapist sits and talks with you.
What's involved
If you join, you will receive either a 15-20 minute massage (hand, foot, or neck/shoulder) or have a massage therapist sit and talk with you for up to 15 minutes during your infusion.
Compensation
Not stated in the trial record.
Follow-up
The study will assess how well it's recruiting and retaining participants for 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07502157

Massage, Oncology, Pain, Anxiety, Feasibility

Recruiting
NAAges 18–85InterventionalSupportive care
Jill Cole
~24 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:Massage TherapyAttention Control

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment feasibility
Measured over 6 months
+4 more outcomes measured
Gynecologic Cancer
1 sites across 1 states
Kentucky1
  • Jill S Cole, MA, LMT, BCTMB · PRINCIPAL_INVESTIGATOR · University of Kentucky, Integrative Medicine and Health

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with gynecologic cancer receiving active treatment of infusion, including but not limited to chemotherapy, immunotherapy, antibiotics, and blood.
Patients with gynecological cancer undergoing an infusion for the first time.

Exclusion

Patient with gynecologic cancer that has received infusion therapy anytime within the past 2 years.
  • Recruitment feasibility6 months

    Number of participants enrolled within the recruitment period.

  • Retention6 months

    Number of participants completing the study.

  • Randomization6 months

    Number of participants randomized

  • Percentage of accessors successful blinded6 months

    Assessors will be answering yes or no to the questionnaire and percentage will be calculated.

  • Number of participants that completed 3 or more sessions6 months

    Adherence is defined by participant completing 3 or more sessions.